Combination chemotherapy and renal enzyme and protein excretion in patients with breast cancer

Breast

Volumn 6, Issue 1, 1997, Pages 26-30

  Cameron, E ^a   Heys, S D ^a   Bruce, D ^a   Eremin, O ^a   Hutcheon, A W ^a   Whiting, P H ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CREATININE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GAMMA GLUTAMYLTRANSFERASE; KIDNEY ENZYME; MICROSOMAL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYMURIA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; TIME; URINALYSIS; VENOUS BLOOD;

EID: 0031040579     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(97)90539-7     Document Type: Article

References (25)

1. Smith I E, Walsh G, Jones A et al. High complete remission rates with primary neo-adjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol 1995; 13: 424-429.
2. Heys S D, Eremin J, Sarkar T K, Hutcheon A W, Ah-See A K, Eremin O. The management of locally advanced breast cancer: the role of multi-modality therapy. J Am Coll Surg 1994; 170: 493-504.
3. Brittenden J, Heys S D, Miller I et al. Dietary supplementation with L-arginine in patients with breast cancer (>4 cm) receiving multimodality treatment. Report of a feasibility study. Br J Cancer 1994; 69: 918-921.
4. Heys S D, Sarkar T K, Ah-See A K, Eremin J M, Brittenden J, Eremin O. Multimodality therapy in the management of locally advanced breast cancer. J Roy Coll Surg Edin 1993; 38: 9-15.
5. Botti C, Vici P, Lopez M, Scinto A F, Cognetti F, Cavaliere R. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am Coll Surg 1995; 181: 202-208.
6. Scholl S M, Asselain B, Palangie T et al. Neoadjuvant chemotherapy in operable breast cancer. Eur J Cancer 1991; 27: 1668-1671.
7. Schwartz G F, Cantor R I, Bierman W A. Neoadjuvant chemotherapy before definitive treatment for Stage III carcinoma of the breast. Arch Surg 1987; 122: 1430-1434.
8. Hortobagyi G N, Singletary S E, Buzdar A V et al. Primary chemotherapy for breast cancer: M D Anderson experience. In: Panzet P, Holland J F, Khayat D, Weil M, eds. Proceedings of the Third International Congress on Neo-adjuvant Chemotherapy. Heidelberg: Springer-Verlag 1991: 146-148.
9. Leonard R C F, Roger A, Dixon J M. Metastatic breast cancer. BMJ 1994; 309: 1501-1504.
10. Silverstrini R, Gambarucci C, Dasdia T. Biological activity of adriamycin in vitro. Tumori 1970; 56: 137-148.
11. Rudolph R, Stein R, Patillo R A. Skin ulcers due to adriamycin. Cancer 1976; 38: 1087-1094.
12. Reilly J J, Neifeld J P, Rosenberg S A. Clinical course and management of accidental adriamycin extravasation. Cancer 1977; 40: 2053-2056.
13. Speyer J L, Green M D, Kramer E et al. Protective effect of ICRF-187 against chronic doxorubicin-induced cardiotoxicity in women with advanced breast cancer. N Engl J Med 1988; 319: 745-752.
14. Griffin-Green E A, Zalesca M M, Erecineska M. Adriamycin-induced lipid peroxidation in mitochondria and microsomes. Biochem Pharmacol 1988; 37: 3071-3077.
15. Priestman T J. Cancer chemotherapy: an introduction, 3rd edn. London: Springer-Verlag 1989, 30.
16. Friedlander G, Blanchet F, Amiel C. Renal functional reserve. Toxicol Lett 1989; 46: 227-235.
17. Price R G, Whiting P H. Urinary enzymes in clinical and experimental medicine. Heidelberg: Springer-Verlag 1992; 203.
18. Grotsch H, Mattenheimer H. Urine. Methods of enzymatic analysis. Weinheim, Verlagchemie, 1983; 42.
19. Whiting P H, Ross I S, Borthwick L C. N-acetyl-β-D-glucosaminidase levels and diabetic microangiopathy. Clin Chim Acta 1979; 97: 191-195.
20. Jung K, Scholz D. An optimised assay of alanine aminopeptidase activity in urine. Clin Chem 1980; 26: 1251-1254.
21. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of of proteindye binding. Anal Biochem 1976; 72: 248-254.
22. Eckman I, Robbins J B, Van den Hamer C J, Lentz J, Scheinberg I H. Automation of a quantitative immunochemical microanalysis of human serum transferrin: a model system. Clin Chem 1970; 16: 558-561.
23. Chasson A L, Grady H J, Stanley M A. Determination of creatinine by means of automatic chemical analysis. Am J Clin Path 1961; 35: 83-88.
24. Guder W G, Ross B D. Enzyme distribution along the nephron. Kidney Int 1984; 28: 178-186.
25. Burnett A J, Whiting P H. Nephrotoxicity: mechanisms, early diagnosis and therapeutic management. Marcel Dekker 1991; 473.